Received May 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 1 | N009800 | — |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 2 | N009800 | — |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 3 | N009800 | — |
HCP called to report a husband and a wife who were "non-responsive" to MMR-II. See AE case #02805024 for documentation of the wife and this AE case #02805008 is for documentation of the husband. Patient received 3 doses of MMR-II in the year 2018.; patient's MMR titers showed no immunity to measles, mumps, and rubella; Patient received 3 doses of MMR-II in the year 2018; This spontaneous report was received from a medical student and refers to a male patient of unknown age. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. In an unspecified date in 2018, the patient was vaccinated with the first, second, and third dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), (lot #N009800, expiration date: 24-Mar-2019)for prophylaxis, diluted with sterile diluent (MERCK STERILE DILUENT), (indication, expiration date, and lot # were not reported) (Inappropriate schedule of product administration). In an unspecified date in April 2025 (also reported as about a month ago), patient's MMR titers showed no immunity to measles, mumps, and rubella. Reporter stated the patient was "non-responsive" to Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II). At the reporting time, the outcome of the events was unknown. The causal relationship between the events and Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) was not provided. This is one of two reports from the same reporter.
Sterile diluent